Ken Rollins


I am an extension of my clients, serving as an advisor at critical inflection points as my clients grow and succeed.

+1 858 550 6136

Ken Rollins represents emerging and late stage private companies and public companies in a wide range of corporate and securities matters, including private financings, public offerings, M&A, tender offers, strategic collaborations, commercial agreements, corporate governance matters and employment and compensation arrangements. He also advises venture capital firms in connection with financings and other transactions. Over the past five years, he has represented companies and venture capitalists in more than 50 private financings and helped clients achieve an aggregate of $5+ billion in successful exit transactions.

Download full bio


  • Synthorx to Sell to Sanofi for $2.5 Billion 

  • Regulus Therapeutics: $50.9 Million Initial Public Offering 

  • Synthorx: $63 Million Series C Financing 

  • AltheaDx: $30 Million Series C Financing 

  • Auspex Pharma $3.5 billion sale to Teva Pharma 

  • View all


  • University of Virginia School of Law
    JD, 2002

  • Southern Utah University
    BA, Accounting
    Valedictorian, 1998

Admissions & Credentials



+1 858 550 6136 office
+1 858 550 6420 fax

4401 Eastgate Mall
San Diego, CA 92121-1909